TAT-cyclo-CLLFVY TFA

Modify Date: 2024-01-14 20:25:21

TAT-cyclo-CLLFVY TFA Structure
TAT-cyclo-CLLFVY TFA structure
Common Name TAT-cyclo-CLLFVY TFA
CAS Number 1446322-66-2 Molecular Weight 2546.86
Density N/A Boiling Point N/A
Molecular Formula C116H176N32O33 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of TAT-cyclo-CLLFVY TFA


TAT-cyclo-CLLFVY is a selective HIF-1 dimerization inhibitor. TAT-cyclo-CLLFVY blocks protein-protein interaction of recombinant HIF-1α, but not HIF-2α, with HIF-1β (IC50=1.3 μM). TAT-cyclo-CLLFVY inhibits hypoxia-induced HIF-1 activity, and decreases VEGF and CAIX expression in osteosarcoma and breast cancer cells in vitro. TAT-cyclo-CLLFVY also reduces tubularization of hypoxic HUVECs.

 Names

Name TAT-cyclo-CLLFVY

 TAT-cyclo-CLLFVY TFA Biological Activity

Description TAT-cyclo-CLLFVY is a selective HIF-1 dimerization inhibitor. TAT-cyclo-CLLFVY blocks protein-protein interaction of recombinant HIF-1α, but not HIF-2α, with HIF-1β (IC50=1.3 μM). TAT-cyclo-CLLFVY inhibits hypoxia-induced HIF-1 activity, and decreases VEGF and CAIX expression in osteosarcoma and breast cancer cells in vitro. TAT-cyclo-CLLFVY also reduces tubularization of hypoxic HUVECs.
Related Catalog

 Chemical & Physical Properties

Molecular Formula C116H176N32O33
Molecular Weight 2546.86

 Safety Information

Hazard Codes Xi
Top Suppliers:I want be here


Get all suppliers and price by the below link:

TAT-cyclo-CLLFVY TFA suppliers

TAT-cyclo-CLLFVY TFA price

Related Compounds: More...
TAT-Gap19 TFA
1507930-54-2
Tat-NR2B9c TFA
1834571-04-8
TAT-DEF-Elk-1
1220751-16-5
Tat-Beclin 1 Peptide
1423821-88-8
TAT 48-57
253141-50-3
TAT 2-4 trifluoroacetate salt
1159916-66-1
tat-BP
94102-64-4
(2R,6S)-6-[[(4R)-4-[[(2S)-2-[[(2R)-2-[[(1R,2S,3R,4R,5R)-4-acetamido-2-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6,8-dioxabicyclo[3.2.1]octan-3-yl]oxy]propanoyl]amino]propanoyl]amino]-4-carboxybutanoyl]amino]-2-amino-7-[[(1
118013-66-4
Tat-NR2B9c
500992-11-0
({1-[5-Fluoro-6-(4-fluorophenyl)pyrimidin-4-yl]azetidin-3-yl}(methyl)sulfamoyl)dimethylamine
2380185-87-3
3-({1-[5-Fluoro-6-(4-methoxyphenyl)pyrimidin-4-yl]azetidin-3-yl}(methyl)amino)pyrazine-2-carbonitrile
2380188-10-1
5-Fluoro-4-(4-methoxyphenyl)-6-[4-(5-methylpyrazine-2-carbonyl)piperazin-1-yl]pyrimidine
2380189-77-3
1-[5-fluoro-6-(4-methoxyphenyl)pyrimidin-4-yl]-N-methyl-N-[(pyridin-3-yl)methyl]azetidin-3-amine
2380192-11-8
1-[5-fluoro-6-(4-methoxyphenyl)pyrimidin-4-yl]-N-methyl-N-[(pyridin-4-yl)methyl]azetidin-3-amine
2380189-24-0
N-[(furan-2-yl)methyl]-N'-{[4-(morpholin-4-yl)thian-4-yl]methyl}ethanediamide
2380178-30-1
1-{4-[(5-ethylpyrimidin-2-yl)oxy]piperidin-1-yl}-2-(1H-indol-1-yl)ethan-1-one
2380181-03-1
3-{4-[(3,5-Dimethyl-1,2-oxazol-4-yl)methyl]piperazin-1-yl}-6-(4-ethoxyphenyl)pyridazine
2380181-26-8
6-(4-Chlorophenyl)-2-[1-(4-methoxy-1-methyl-6-oxo-1,6-dihydropyridine-3-carbonyl)azetidin-3-yl]-2,3-dihydropyridazin-3-one
2380185-11-3
4-(2-Oxoimidazolidine-1-carbonyl)-1-(pyridin-2-yl)piperazin-2-one
2380191-18-2